Mass spectrometric studies on epigenetic interaction networks in cell differentiation

Area of Science:

• Molecular Biology
• Epigenetics
• Cancer Research

Background:

• Cell differentiation arrest is a major driver of leukemia and other cancers.
• Pharmaceutical induction of cell differentiation is a therapeutic strategy for these malignancies.
• Epigenetic regulation plays a crucial role in controlling cell proliferation and differentiation.

Purpose of the Study:

• To elucidate the interplay between epigenetic modifications, their associated enzymes, and pathway alterations during cell differentiation.
• To investigate the molecular mechanisms underlying cancer cell differentiation using a systems biology approach.

Main Methods:

• Proteomics-based differential protein expression analysis.
• Quantification of histone modifications.
• Analysis of phorbol-12-myristate 13-acetate-induced differentiation in U937 cells.

Main Results:

• Upregulation of fatty acid synthesis, clathrin-coated pit endocytosis, and ubiquitin/26 S proteasome degradation pathways during U937 cell differentiation.
• Downregulation of global histone H3/H4 acetylation and H2B ubiquitination, alongside impaired chromatin remodeling, RNA polymerase II complexes, and DNA replication.
• Established networks linking histone hypoacetylation to p300 activity and H2B ubiquitination to the RNA polymerase II-associated FACT-RTF1-PAF1 complex.

Conclusions:

• The study provides a systemic view of epigenetic regulation's role in leukemia cell differentiation.
• Identified specific molecular links between histone modifications and key cellular processes during differentiation.
• Offers insights into potential therapeutic targets for epigenetic-based cancer treatments.